# A Study Investigating the Distribution and Metabolism of Three 14C-labeled Radioactive Study Compounds

> **NCT04676906** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 18 (actual)

## Conditions studied

- Healthy Volunteers
- Type 2 Diabetes

## Interventions

- **DRUG:** NNC0113-6861
- **DRUG:** NNC0113-6860
- **DRUG:** NNC0113-6891

## Key facts

- **NCT ID:** NCT04676906
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-26
- **Primary completion:** 2021-04-28
- **Final completion:** 2021-04-28
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04676906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04676906, "A Study Investigating the Distribution and Metabolism of Three 14C-labeled Radioactive Study Compounds". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04676906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*